PEP-CMV + Nivolumab for Newly Diagnosed Diffuse Midline Glioma/High-grade Glioma and Recurrent Diffuse Midline Glioma/High-grade Glioma, Medulloblastoma, and Ependymoma
Abroad (travel likely)Not Yet RecruitingPHASE1, PHASE2
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Conditions
Diffuse Midline Glioma · Diffuse Midline High-grade Glioma · Medulloblastoma · Ependymoma
Locations
- Washington University School of Medicine, St Louis, Missouri, United States
- Duke University Medical Center, Durham, North Carolina, United States
- MD Anderson Cancer Center, Houston, Texas, United States